Targeson lands supplemental funding

Ultrasound imaging technology developer Targeson is receiving funding from the U.S. National Institutes of Health (NIH) for its kidney disease therapy initiative.

The project will explore how therapeutic substances can be delivered to the kidney by ultrasound using Targeson's microbubble platform as a high-efficiency targeted contrast agent, according to the San Diego-based vendor.

Related Reading

Targeson lands SBIR funding, March 30, 2010

Targeson moves to San Diego, December 16, 2009

Targeson launches US contrast agent, August 26, 2009

Targeson debuts US contrast agent, August 11, 2009

Copyright © 2010 AuntMinnie.com

Page 1 of 512
Next Page